France, Villejuif 
Dr. Jean-Pierre Armand is a senior medical oncologist and internationally recognized leader in early drug development and translational oncology, based at Gustave Roussy. With decades of experience, he has played a pivotal role in advancing phase I–III clinical trials, oncology drug development, and European cancer research leadership.
Current Position
- Senior Consultant in Medical Oncology, Gustave Roussy
- Senior Consultant, Chinese Academy of Sciences
- Chairman of the Board, PEGASCY (oncology biotech company)
- Honorary Professor of Oncology, Yunnan University
Education
- MD in Oncology, Université Paul Sabatier Toulouse III
- Research Fellowship, Columbia University
- Master’s Degree (MSc), Paris-Sud University
Clinical & Research Focus
- Early-phase clinical trials (Phase I–III) in solid tumors
- Oncology drug development and repurposing strategies
- Translational oncology and experimental therapeutics
- Support of oncology biotech innovation
Academic Profile
- Extensive publication record and contributions to oncology literature
- Author of scientific and academic works including books in oncology
- Long-standing involvement in international cancer research collaborations
Research Innovation & Programs
Dr. Armand has been a pioneer in early drug development and oncology innovation:
- He led early clinical drug development programs at Gustave Roussy, focusing on novel anticancer agents
- He co-founded PEGASCY, a biotech company focused on repurposing previously discarded drugs from early-phase trials
- He has been actively involved in phase I–III clinical trials for solid tumors across international research networks
- His work bridges academic oncology and biotech innovation to accelerate therapeutic development
Leadership & Contributions
- Former President of European Society for Medical Oncology
- Former Medical Director of the Federation of European Cancer Societies (FECS)
- Former President of the French Cancer Society (SFC)
- Former Chairman of the Protocol Review Committee at European Organisation for Research and Treatment of Cancer
- Member of international advisory and scientific boards including American Association for Cancer
- Research and American Society of Clinical Oncology
Awards & Recognition
- ESMO Award – European Oncologist of the Year (2008)
- TAT Award for early drug development in oncology (2012)
- Legion of Honour, France
- Multiple international awards recognizing contributions to oncology research and leadership